p53/E2F7 axis promotes temozolomide chemoresistance in glioblastoma multiformeMeng Jiao(Wuxi People's Hospital), Jian Zou(Wuxi People's Hospital)BMC CancerMarch 7, 202410.1186/s12885-024-12017-yCited by 9SaveCiteExport RISWatch citationsRelated PapersCharacterization of EGFR-reprogrammable temozolomide-resistant cells in a model of glioblastoma|Cell Death Discovery|2022|27PKCγ promotes axonal remodeling in the cortico-spinal tract via GSK3β/β-catenin signaling after traumatic brain injury|Scientific Reports|2019|17Acetylation halts missense mutant p53 aggregation and rescues tumor suppression in non-small cell lung cancers|iScience|2023|10